Close rivalries among European haemophilia A medical affairs teams. Will your team come out on top?
With just over 3 points separating the top 7 haemophilia A medical affairs teams in Europe, there is all to play for in reaching top spot. What is the leading team doing so well? And what could other teams do to gain critically important points to close the gap?
Nearly 150 haematologists from the leading EU5 markets (France, Germany, Italy, Spain and the UK) provide insights on several medical affairs teams, and opinions are mixed. Will targeting improvements in certain areas be enough to put your team ahead of the competition?
Discover all the ways you can improve your medical affairs services in Medical Affairs Reputations: Haemophilia A (EU5) [2018]. This report, which compares the current activities of medical affairs teams for the 13 leading treatments for haemophilia A from Shire, Swedish Orphan Biovitrum, Grifols, Roche, CSL Behring, Bayer, Novo Nordisk, Pfizer and Octapharma, reveals:
That’s actionable information you can use to turn your team into one that doctors rely on.
Interested in the US market? Click here to see the US Edition.
Developed with the help of medical affairs specialists, this report gives you an in-depth comparison of 13 medical affairs teams—answering important questions like:
What do doctors need?
Does your medical affairs team deliver?
What needs improvement?
We surveyed nearly 150 haematologists from the EU5 (France, Italy, Germany, Spain, UK)—chosen from the largest community of validated physicians in the world.
All respondents:
We conducted the survey between October 4-30, 2018.
At FirstWord, we stand behind our reports. If you're not completely satisfied, we’ll refund your money. Guaranteed.
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
Learn more at www.firstwordgroup.com.
All Contents Copyright © 2019 Doctor's Guide Publishing Limited All Rights Reserved